Chapter/Section Purchase

1 Study Coverage
1.1 Anthrax Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Anthrax Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Live Vaccines
1.2.3 Cell free PA Vaccines
1.3 Market by Application
1.3.1 Global Anthrax Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Human Use
1.3.3 Animal Use
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Anthrax Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global Anthrax Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global Anthrax Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Anthrax Vaccines Sales by Region
2.4.1 Global Anthrax Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales Anthrax Vaccines by Region (2023-2028)
2.5 Global Anthrax Vaccines Revenue by Region
2.5.1 Global Anthrax Vaccines Revenue by Region (2017-2022)
2.5.2 Global Anthrax Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Anthrax Vaccines Sales by Manufacturers
3.1.1 Global Top Anthrax Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global Anthrax Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anthrax Vaccines in 2021
3.2 Global Anthrax Vaccines Revenue by Manufacturers
3.2.1 Global Anthrax Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global Anthrax Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Anthrax Vaccines Revenue in 2021
3.3 Global Anthrax Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Anthrax Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Anthrax Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Anthrax Vaccines Sales by Type
4.1.1 Global Anthrax Vaccines Historical Sales by Type (2017-2022)
4.1.2 Global Anthrax Vaccines Forecasted Sales by Type (2023-2028)
4.1.3 Global Anthrax Vaccines Sales Market Share by Type (2017-2028)
4.2 Global Anthrax Vaccines Revenue by Type
4.2.1 Global Anthrax Vaccines Historical Revenue by Type (2017-2022)
4.2.2 Global Anthrax Vaccines Forecasted Revenue by Type (2023-2028)
4.2.3 Global Anthrax Vaccines Revenue Market Share by Type (2017-2028)
4.3 Global Anthrax Vaccines Price by Type
4.3.1 Global Anthrax Vaccines Price by Type (2017-2022)
4.3.2 Global Anthrax Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Anthrax Vaccines Sales by Application
5.1.1 Global Anthrax Vaccines Historical Sales by Application (2017-2022)
5.1.2 Global Anthrax Vaccines Forecasted Sales by Application (2023-2028)
5.1.3 Global Anthrax Vaccines Sales Market Share by Application (2017-2028)
5.2 Global Anthrax Vaccines Revenue by Application
5.2.1 Global Anthrax Vaccines Historical Revenue by Application (2017-2022)
5.2.2 Global Anthrax Vaccines Forecasted Revenue by Application (2023-2028)
5.2.3 Global Anthrax Vaccines Revenue Market Share by Application (2017-2028)
5.3 Global Anthrax Vaccines Price by Application
5.3.1 Global Anthrax Vaccines Price by Application (2017-2022)
5.3.2 Global Anthrax Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Anthrax Vaccines Market Size by Type
6.1.1 North America Anthrax Vaccines Sales by Type (2017-2028)
6.1.2 North America Anthrax Vaccines Revenue by Type (2017-2028)
6.2 North America Anthrax Vaccines Market Size by Application
6.2.1 North America Anthrax Vaccines Sales by Application (2017-2028)
6.2.2 North America Anthrax Vaccines Revenue by Application (2017-2028)
6.3 North America Anthrax Vaccines Market Size by Country
6.3.1 North America Anthrax Vaccines Sales by Country (2017-2028)
6.3.2 North America Anthrax Vaccines Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Anthrax Vaccines Market Size by Type
7.1.1 Europe Anthrax Vaccines Sales by Type (2017-2028)
7.1.2 Europe Anthrax Vaccines Revenue by Type (2017-2028)
7.2 Europe Anthrax Vaccines Market Size by Application
7.2.1 Europe Anthrax Vaccines Sales by Application (2017-2028)
7.2.2 Europe Anthrax Vaccines Revenue by Application (2017-2028)
7.3 Europe Anthrax Vaccines Market Size by Country
7.3.1 Europe Anthrax Vaccines Sales by Country (2017-2028)
7.3.2 Europe Anthrax Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Anthrax Vaccines Market Size by Type
8.1.1 Asia Pacific Anthrax Vaccines Sales by Type (2017-2028)
8.1.2 Asia Pacific Anthrax Vaccines Revenue by Type (2017-2028)
8.2 Asia Pacific Anthrax Vaccines Market Size by Application
8.2.1 Asia Pacific Anthrax Vaccines Sales by Application (2017-2028)
8.2.2 Asia Pacific Anthrax Vaccines Revenue by Application (2017-2028)
8.3 Asia Pacific Anthrax Vaccines Market Size by Region
8.3.1 Asia Pacific Anthrax Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific Anthrax Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Anthrax Vaccines Market Size by Type
9.1.1 Latin America Anthrax Vaccines Sales by Type (2017-2028)
9.1.2 Latin America Anthrax Vaccines Revenue by Type (2017-2028)
9.2 Latin America Anthrax Vaccines Market Size by Application
9.2.1 Latin America Anthrax Vaccines Sales by Application (2017-2028)
9.2.2 Latin America Anthrax Vaccines Revenue by Application (2017-2028)
9.3 Latin America Anthrax Vaccines Market Size by Country
9.3.1 Latin America Anthrax Vaccines Sales by Country (2017-2028)
9.3.2 Latin America Anthrax Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Anthrax Vaccines Market Size by Type
10.1.1 Middle East and Africa Anthrax Vaccines Sales by Type (2017-2028)
10.1.2 Middle East and Africa Anthrax Vaccines Revenue by Type (2017-2028)
10.2 Middle East and Africa Anthrax Vaccines Market Size by Application
10.2.1 Middle East and Africa Anthrax Vaccines Sales by Application (2017-2028)
10.2.2 Middle East and Africa Anthrax Vaccines Revenue by Application (2017-2028)
10.3 Middle East and Africa Anthrax Vaccines Market Size by Country
10.3.1 Middle East and Africa Anthrax Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa Anthrax Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Emergent BioSolutions
11.1.1 Emergent BioSolutions Corporation Information
11.1.2 Emergent BioSolutions Overview
11.1.3 Emergent BioSolutions Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Emergent BioSolutions Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Emergent BioSolutions Recent Developments
11.2 Merial
11.2.1 Merial Corporation Information
11.2.2 Merial Overview
11.2.3 Merial Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Merial Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merial Recent Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Overview
11.3.3 Merck Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Merck Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck Recent Developments
11.4 Zoetis
11.4.1 Zoetis Corporation Information
11.4.2 Zoetis Overview
11.4.3 Zoetis Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Zoetis Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Zoetis Recent Developments
11.5 Bayer Sanidad Animal
11.5.1 Bayer Sanidad Animal Corporation Information
11.5.2 Bayer Sanidad Animal Overview
11.5.3 Bayer Sanidad Animal Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Bayer Sanidad Animal Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Bayer Sanidad Animal Recent Developments
11.6 Colorado Serum
11.6.1 Colorado Serum Corporation Information
11.6.2 Colorado Serum Overview
11.6.3 Colorado Serum Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Colorado Serum Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Colorado Serum Recent Developments
11.7 PharmAthene
11.7.1 PharmAthene Corporation Information
11.7.2 PharmAthene Overview
11.7.3 PharmAthene Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 PharmAthene Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 PharmAthene Recent Developments
11.8 Tiankang
11.8.1 Tiankang Corporation Information
11.8.2 Tiankang Overview
11.8.3 Tiankang Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Tiankang Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Tiankang Recent Developments
11.9 Biog?nesis-Bago
11.9.1 Biog?nesis-Bago Corporation Information
11.9.2 Biog?nesis-Bago Overview
11.9.3 Biog?nesis-Bago Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Biog?nesis-Bago Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Biog?nesis-Bago Recent Developments
11.10 CAVAC
11.10.1 CAVAC Corporation Information
11.10.2 CAVAC Overview
11.10.3 CAVAC Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 CAVAC Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 CAVAC Recent Developments
11.11 Rosenbusch
11.11.1 Rosenbusch Corporation Information
11.11.2 Rosenbusch Overview
11.11.3 Rosenbusch Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Rosenbusch Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Rosenbusch Recent Developments
11.12 Agrovet
11.12.1 Agrovet Corporation Information
11.12.2 Agrovet Overview
11.12.3 Agrovet Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Agrovet Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Agrovet Recent Developments
11.13 Vecol
11.13.1 Vecol Corporation Information
11.13.2 Vecol Overview
11.13.3 Vecol Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Vecol Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Vecol Recent Developments
11.14 CVCRI
11.14.1 CVCRI Corporation Information
11.14.2 CVCRI Overview
11.14.3 CVCRI Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 CVCRI Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 CVCRI Recent Developments
11.15 IVPM
11.15.1 IVPM Corporation Information
11.15.2 IVPM Overview
11.15.3 IVPM Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 IVPM Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 IVPM Recent Developments
11.16 Prondil
11.16.1 Prondil Corporation Information
11.16.2 Prondil Overview
11.16.3 Prondil Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Prondil Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Prondil Recent Developments
11.17 CDV
11.17.1 CDV Corporation Information
11.17.2 CDV Overview
11.17.3 CDV Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 CDV Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 CDV Recent Developments
11.18 Indian Immunologicals
11.18.1 Indian Immunologicals Corporation Information
11.18.2 Indian Immunologicals Overview
11.18.3 Indian Immunologicals Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Indian Immunologicals Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Indian Immunologicals Recent Developments
11.19 Botswana Vaccine Institute
11.19.1 Botswana Vaccine Institute Corporation Information
11.19.2 Botswana Vaccine Institute Overview
11.19.3 Botswana Vaccine Institute Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Botswana Vaccine Institute Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Botswana Vaccine Institute Recent Developments
11.20 Ceva Sant? Animale
11.20.1 Ceva Sant? Animale Corporation Information
11.20.2 Ceva Sant? Animale Overview
11.20.3 Ceva Sant? Animale Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Ceva Sant? Animale Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Ceva Sant? Animale Recent Developments
11.21 Intervac
11.21.1 Intervac Corporation Information
11.21.2 Intervac Overview
11.21.3 Intervac Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 Intervac Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Intervac Recent Developments
11.22 JOVAC
11.22.1 JOVAC Corporation Information
11.22.2 JOVAC Overview
11.22.3 JOVAC Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.22.4 JOVAC Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 JOVAC Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Anthrax Vaccines Industry Chain Analysis
12.2 Anthrax Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Anthrax Vaccines Production Mode & Process
12.4 Anthrax Vaccines Sales and Marketing
12.4.1 Anthrax Vaccines Sales Channels
12.4.2 Anthrax Vaccines Distributors
12.5 Anthrax Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Anthrax Vaccines Industry Trends
13.2 Anthrax Vaccines Market Drivers
13.3 Anthrax Vaccines Market Challenges
13.4 Anthrax Vaccines Market Restraints
14 Key Findings in The Global Anthrax Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer